Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Notes Payables (2021 - 2022)

Historic Notes Payables for BioScience Health Innovations (BHIC) over the last 2 years, with Q2 2022 value amounting to $7050.0.

  • BioScience Health Innovations' Notes Payables changed N/A to $7050.0 in Q2 2022 from the same period last year, while for May 2022 it was $7050.0, marking a year-over-year change of. This contributed to the annual value of $7050.0 for FY2021, which is N/A changed from last year.
  • Per BioScience Health Innovations' latest filing, its Notes Payables stood at $7050.0 for Q2 2022.
  • BioScience Health Innovations' 5-year Notes Payables high stood at $7050.0 for Q3 2021, and its period low was $7050.0 during Q3 2021.